BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang LC, Wang Y, Tong LC, Sun S, Liu WY, Zhang S, Wang RM, Wang ZB, Li L. Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Exp Ther Med 2017;13:3374-82. [PMID: 28587416 DOI: 10.3892/etm.2017.4402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Front Pharmacol 2021;12:684486. [PMID: 34335253 DOI: 10.3389/fphar.2021.684486] [Reference Citation Analysis]
2 Jiang Y, Zhao L, Chen Q, Zhou L. Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology. Evid Based Complement Alternat Med 2021;2021:9970240. [PMID: 34211579 DOI: 10.1155/2021/9970240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Jia L, Xue K, Liu J, Habotta OA, Hu L, Abdel Moneim AE. Anticolitic Effect of Berberine in Rat Experimental Model: Impact of PGE2/p38 MAPK Pathways. Mediators Inflamm 2020;2020:9419085. [PMID: 33061833 DOI: 10.1155/2020/9419085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Li H, Fan C, Lu H, Feng C, He P, Yang X, Xiang C, Zuo J, Tang W. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions. Acta Pharm Sin B 2020;10:447-61. [PMID: 32140391 DOI: 10.1016/j.apsb.2019.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
5 Chen H, Zhang F, Li R, Liu Y, Wang X, Zhang X, Xu C, Li Y, Guo Y, Yao Q. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota. Biomed Pharmacother 2020;124:109829. [PMID: 31958765 DOI: 10.1016/j.biopha.2020.109829] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
6 Hossen I, Hua W, Ting L, Mehmood A, Jingyi S, Duoxia X, Yanping C, Hongqing W, Zhipeng G, Kaiqi Z, Fang Y, Junsong X. Phytochemicals and inflammatory bowel disease: a review. Crit Rev Food Sci Nutr 2020;60:1321-45. [PMID: 30729797 DOI: 10.1080/10408398.2019.1570913] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
7 Hallajzadeh J, Maleki Dana P, Mobini M, Asemi Z, Mansournia MA, Sharifi M, Yousefi B. Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer. Med Oncol 2020;37:49. [PMID: 32303850 DOI: 10.1007/s12032-020-01367-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
8 Li YH, Sun W, Zhou BJ, Rosenstein A, Zhao J, Wang J, Bian ZX. iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis. Eur J Pharmacol 2019;850:167-79. [PMID: 30771347 DOI: 10.1016/j.ejphar.2019.02.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Liu X, Fan Y, Du L, Mei Z, Fu Y. In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis. Front Pharmacol 2021;12:665102. [PMID: 34177580 DOI: 10.3389/fphar.2021.665102] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhai L, Huang T, Xiao HT, Wu PG, Lin CY, Ning ZW, Zhao L, Kwan HYA, Hu XJ, Wong HLX, Li XQ, Bian ZX. Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium-Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity. Front Pharmacol 2020;11:576496. [PMID: 33658925 DOI: 10.3389/fphar.2020.576496] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tang Z, Xiong D, Song J, Ye M, Liu J, Wang Z, Zhang L, Xiao X. Antitumor Drug Combretastatin-A4 Phosphate Aggravates the Symptoms of Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front Pharmacol 2020;11:339. [PMID: 32265711 DOI: 10.3389/fphar.2020.00339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu J, Liu L, Gan L, Hu Y, Xiang P, Xing Y, Zhu J, Ye S. Berberine Acts on C/EBPβ/lncRNA Gas5/miR-18a-5p Loop to Decrease the Mitochondrial ROS Generation in HK-2 Cells. Front Endocrinol (Lausanne) 2021;12:675834. [PMID: 34526965 DOI: 10.3389/fendo.2021.675834] [Reference Citation Analysis]
13 Mandal SK, Maji AK, Mishra SK, Ishfaq PM, Devkota HP, Silva AS, Das N. Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues. Pharmacol Res 2020;160:105085. [PMID: 32683037 DOI: 10.1016/j.phrs.2020.105085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang L, Cao N, Wang Y, Wang Y, Wu C, Cheng X, Wang C. Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide. Molecules 2019;25:E76. [PMID: 31878303 DOI: 10.3390/molecules25010076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Ma X, Hu Y, Li X, Zheng X, Wang Y, Zhang J, Fu C, Geng F. Periplaneta americana Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation. Front Pharmacol. 2018;9:944. [PMID: 30186174 DOI: 10.3389/fphar.2018.00944] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
16 Gai L, Chu L, Xia R, Chen Q, Sun X. Barbaloin Attenuates Mucosal Damage in Experimental Models of Rat Colitis by Regulating Inflammation and the AMPK Signaling Pathway. Med Sci Monit 2019;25:10045-56. [PMID: 31881016 DOI: 10.12659/MSM.918935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kong WJ, Vernieri C, Foiani M, Jiang JD. Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders. Pharmacol Ther 2020;209:107496. [PMID: 32001311 DOI: 10.1016/j.pharmthera.2020.107496] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
18 Komaki S, Haque A, Miyazaki H, Matsumoto T, Nakamura S. Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice. J Infect Chemother 2020;26:549-53. [PMID: 32122783 DOI: 10.1016/j.jiac.2020.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lee H, Lee JS, Cho HJ, Lee YJ, Kim ES, Kim SK, Nam TG, Jeong BS, Kim JA. Antioxidant Analogue 6-Amino-2,4,5-Trimethylpyridin-3-ol Ameliorates Experimental Colitis in Mice. Dig Dis Sci 2021;66:1022-33. [PMID: 32361923 DOI: 10.1007/s10620-020-06267-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang L, Li M, Zhang G, Gao C, Wang S, Zhang T, Ma C, Wang L, Zhu Q. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine. Mol Pharm 2021;18:1573-81. [PMID: 33629860 DOI: 10.1021/acs.molpharmaceut.0c00970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Huang Y, Yin J, Gao J, Wang Y, Dong L, Zhao J. Portulacaoleraceal extract alleviates trinitrobenzene sulfonic acid-induced colitis in rats. Biomedicine & Pharmacotherapy 2018;105:434-9. [DOI: 10.1016/j.biopha.2018.05.133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li Q, Qu X, Pang X, Song Y, Chen L, Xiao Q, Sun L, Wang X, Zhang H, Qi D, Wang Z. Berberine Protects Mice Against Dextran Sulfate Sodium-Induced Colitis by Activating mTORC1 Pathway. Front Pharmacol 2019;10:786. [PMID: 31354497 DOI: 10.3389/fphar.2019.00786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Zu M, Ma Y, Cannup B, Xie D, Jung Y, Zhang J, Yang C, Gao F, Merlin D, Xiao B. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv Drug Deliv Rev 2021;:113887. [PMID: 34314785 DOI: 10.1016/j.addr.2021.113887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yang Y, Vong CT, Zeng S, Gao C, Chen Z, Fu C, Wang S, Zou L, Wang A, Wang Y. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies. J Ethnopharmacol 2021;268:113573. [PMID: 33181286 DOI: 10.1016/j.jep.2020.113573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Li H, Feng C, Fan C, Yang Y, Yang X, Lu H, Lu Q, Zhu F, Xiang C, Zhang Z, He P, Zuo J, Tang W. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. Cell Death Dis 2020;11:271. [PMID: 32332711 DOI: 10.1038/s41419-020-2470-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
26 Zhou Z, Lin Y, Gao L, Yang Z, Wang S, Wu B. Circadian pharmacological effects of berberine on chronic colitis in mice: Role of the clock component Rev-erbα. Biochem Pharmacol 2020;172:113773. [PMID: 31866303 DOI: 10.1016/j.bcp.2019.113773] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
27 Ashrafizadeh M, Najafi M, Mohammadinejad R, Farkhondeh T, Samarghandian S. Berberine Administration in Treatment of Colitis: A Review. Curr Drug Targets 2020;21:1385-93. [PMID: 32564751 DOI: 10.2174/1389450121666200621193758] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Huang L, Zhang X, Ma X, Zhang D, Li D, Feng J, Pan X, Lü J, Wang X, Liu X. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS. Int Immunopharmacol 2018;65:96-107. [PMID: 30308440 DOI: 10.1016/j.intimp.2018.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
29 Liao J, Li Q, Lei C, Yu W, Deng J, Guo J, Han Q, Hu L, Li Y, Pan J, Zhang H, Chang YF, Tang Z. Toxic effects of copper on the jejunum and colon of pigs: mechanisms related to gut barrier dysfunction and inflammation influenced by the gut microbiota. Food Funct 2021;12:9642-57. [PMID: 34664585 DOI: 10.1039/d1fo01286j] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Moon SY, Kim KD, Yoo J, Lee JH, Hwangbo C. Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models. Molecules 2021;26:2824. [PMID: 34068714 DOI: 10.3390/molecules26092824] [Reference Citation Analysis]
31 Ruiz Castro PA, Kogel U, Lo Sasso G, Phillips BW, Sewer A, Titz B, Garcia L, Kondylis A, Guedj E, Peric D, Bornand D, Dulize R, Merg C, Corciulo M, Ivanov NV, Peitsch MC, Hoeng J. Anatabine ameliorates intestinal inflammation and reduces the production of pro-inflammatory factors in a dextran sulfate sodium mouse model of colitis. J Inflamm (Lond) 2020;17:29. [PMID: 32855621 DOI: 10.1186/s12950-020-00260-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zhao R, Long X, Yang J, Du L, Zhang X, Li J, Hou C. Pomegranate peel polyphenols reduce chronic low-grade inflammatory responses by modulating gut microbiota and decreasing colonic tissue damage in rats fed a high-fat diet.Food Funct. 2019;10:8273-8285. [PMID: 31720661 DOI: 10.1039/c9fo02077b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 17.0] [Reference Citation Analysis]
33 Cao SY, Ye SJ, Wang WW, Wang B, Zhang T, Pu YQ. Progress in active compounds effective on ulcerative colitis from Chinese medicines. Chin J Nat Med 2019;17:81-102. [PMID: 30797423 DOI: 10.1016/S1875-5364(19)30012-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
34 Xiong X, Cheng Z, Wu F, Hu M, Liu Z, Dong R, Chen G. Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells. Biomed Pharmacother 2021;134:111129. [PMID: 33348308 DOI: 10.1016/j.biopha.2020.111129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Zhang D, Jiang L, Wang M, Jin M, Zhang X, Liu D, Wang Z, Yang L, Xu X. Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration. J Ethnopharmacol 2021;264:113206. [PMID: 32750460 DOI: 10.1016/j.jep.2020.113206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lv P, Chen T, Liu P, Zheng L, Tian J, Tan F, Chen J, Deng Y, Li J, Cai J, Chi X. Dexmedetomidine Attenuates Orthotopic Liver Transplantation-Induced Acute Gut Injury via α 2-Adrenergic Receptor-Dependent Suppression of Oxidative Stress. Oxid Med Cell Longev 2019;2019:9426368. [PMID: 31827710 DOI: 10.1155/2019/9426368] [Reference Citation Analysis]
37 Marescotti D, Lo Sasso G, Guerrera D, Renggli K, Ruiz Castro PA, Piault R, Jaquet V, Moine F, Luettich K, Frentzel S, Peitsch MC, Hoeng J. Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds. Front Pharmacol 2021;12:639716. [PMID: 33935729 DOI: 10.3389/fphar.2021.639716] [Reference Citation Analysis]
38 Li T, Wu M, Wang L, Song X, Feng P. Huang Lian for ulcerative colitis: A protocol of systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore) 2020;99:e22457. [PMID: 33019433 DOI: 10.1097/MD.0000000000022457] [Reference Citation Analysis]
39 Yao D, Dong M, Dai C, Wu S. Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer. Inflammatory Bowel Diseases 2019;25:1595-602. [DOI: 10.1093/ibd/izz149] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 17.5] [Reference Citation Analysis]
40 Yao W, Wang X, Xiao K. Protective effect of berberine against cardiac ischemia/reperfusion injury by inhibiting apoptosis through the activation of Smad7. Mol Cell Probes 2018;38:38-44. [PMID: 29278748 DOI: 10.1016/j.mcp.2017.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
41 Fusi J, Bianchi S, Daniele S, Pellegrini S, Martini C, Galetta F, Giovannini L, Franzoni F. An in vitro comparative study of the antioxidant activity and SIRT1 modulation of natural compounds. Biomed Pharmacother 2018;101:805-19. [PMID: 29525677 DOI: 10.1016/j.biopha.2018.03.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
42 Lu PD, Zhao YH. Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med 2020;15:15. [PMID: 32063999 DOI: 10.1186/s13020-020-0296-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
43 Peng J, Zheng TT, Li X, Liang Y, Wang LJ, Huang YC, Xiao HT. Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease. Front Pharmacol 2019;10:351. [PMID: 31031622 DOI: 10.3389/fphar.2019.00351] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]